Progress in diagnosis and treatment of oral and maxillofacial hemangioma

doi:10.19438/j.cjoms.2018.06.014

Abstract

Abstract: Oral and maxillofacial hemangioma is a common congenital hemangioma, it is one of the common tumors of soft tissue which often had bad effects on the morphology and function of normal tissue, or even be life-threatening in serious cases. Although its pathogenesis has not been fully understood until now, a diagnosis could be made based on symptoms, signs, imagology and pathology. With the development of technology, various methods are gradually applied in the treatment of the disease, which brings good news to patients with oral and maxillofacial hemangioma. This review was aimed to summarize the latest advances in the diagnosis and treatment of oral and maxillofacial hemangioma.

Key words: Oral and maxillofacial hemangioma, Diagnosis, Treatment

CLC Number:

R739.8

ZHOU Zi-jun, ZHANG Jing. Progress in diagnosis and treatment of oral and maxillofacial hemangioma[J]. China Journal of Oral and Maxillofacial Surgery, 2018, 16(6): 563-567.

References

[1] 刘国林, 闫威, 陈勇,等. 平阳霉素联合地塞米松灌注治疗婴幼儿颌面部血管瘤的疗效评价[J]. 国际口腔医学杂志, 2009, 36(6): 669-671.
[2] Chang LC, Haggstrom AN, Drolet BA, et al.Growth characteristics of infantile hemangiomas: implications for management[J]. Pediatrics, 2008, 122(2): 360-367.
[3] Wassef M, Blei F, Adams D, et al.Vascular anomalies classification: recommendations from the international society for the study of vascular anomalies[J]. Pediatrics, 2015, 136(1): e203-e214.
[4] Kleinman ME, Greives MR, Churgin SS, et al.Hypoxia-induced mediators of stem/progenitor cell trafficking are increased in children with hemangioma[J]. Arterioscler Thromb Vasc Biol, 2007, 27(12): 2664-2670.
[5] Sasaki GH, Pang CY, Wittliff JL.Pathogenesis and treatment of infant skin strawberry hemangiomas: clinical and in vitro studies of hormonal effects[J]. Plast Reconstr Surg, 1984, 73(3): 359-370.
[6] Picard A, Boscolo E, Khan ZA, et al.IGF-2 and FLT-1/VEGF-R1 mRNA levels reveal distinctions and similarities between congenital and common infantile hemangioma[J]. Pediatr Res, 2008, 63(3): 263-267.
[7] Chang EI, Chang EI, Thangarajah H, et al.Hypoxia, hormones, and endothelial progenitor cells in hemangioma[J]. Lymphat Res Biol, 2007, 5(4): 237-243.
[8] Przewratil P, Sitkiewicz A, Wyka K, et al.Serum levels of vascular endothelial growth factor and basic fibroblastic growth factor in children with hemangiomas and vascular malformations-preliminary report[J]. Pediatr Dermatol, 2009, 26(4): 399-404.
[9] Przewratil P, Sitkiewicz A, Andrzejewska E.Serum levels of basic fibroblastic growth factor (bFGF) in children with vascular anomalies: Another insight into endothelial growth[J]. Clin Biochem, 2010, 43(10-11): 863-867.
[10] Song JK, Niimi Y, Berenstein A.Endovascular treatment of hemangiomas[J]. Neuroimaging Clin N Am, 2007, 17(2): 165-173.
[11] Mulliken JB, Fishman SJ, Burrows PE.Vascular anomalies[J]. Curr Probl Surg, 2000, 37(8): 517-584.
[12] Dilsiz A, Aydin T, Gursan N.Capillary hemangioma as a rare benign tumor of the oral cavity: a case report[J]. Cases J, 2009, 2: 8622.
[13] Richter GT, Friedman AB.Hemangiomas and vascular malformations: current theory and management[J]. Int J Pediatr, 2012, 2012: 645678.
[14] 雷红召, 孟小分, 董长宪, 等. 颈外动脉置管药物灌注治疗婴幼儿口腔颌面部重症血管瘤的疗效[J]. 中华实用儿科临床杂志, 2016, 31(18): 1432-1434.
[15] 中华口腔医学会口腔颌面外科专业委员会脉管性疾病学组. 口腔颌面部动静脉畸形诊治指南[J]. 中国口腔颌面外科杂志, 2011, 9(3): 242-247.
[16] Ritter MR, Butschek RA, Friedlander M, et al.Pathogenesis of infantile haemangioma: new molecular and cellular insights[J]. Expert Rev Mol Med, 2007, 9(32): 1-19.
[17] Schlosser KA.Infantile hemangioma: how to treat this benign neoplasm of childhood[J]. JAAPA, 2009, 22(5): 46-49.
[18] 舒艳, 汤炜健, 汤宏峰, 等. 32例先天性血管瘤临床病理特征及诊治分析[J]. 中华小儿外科杂志, 2016, 37(11): 823-827.
[19] 高健. 小儿颌面部血管瘤50例超声诊断与病理分析[J]. 中国社区医师(医学专业), 2009, 11(22): 176.
[20] Razon MJ, Kräling BM, Mulliken JB, et al.Increased apoptosis coincides with onset of involution in infantile hemangioma[J]. Microcirculation, 1998, 5(2-3): 189-195.
[21] 高维青, 张春叶, 郑家伟, 等. 口腔颌面部肌间血管瘤不同病理分型的影像学表现[J]. 中国口腔颌面外科杂志, 2015, 13(6): 558-562.
[22] Burns CM, Rutherford MJ, Cowan F, et al.Patterns of cerebral injury and neurodevelopmental outcomes after symptomatic neonatal hypoglycemia[J]. Pediatrics, 2008, 122(1): 65-74.
[23] 张靖, 周少毅, 陈昆山, 等. 经导管动脉硬化栓塞联合注射硬化治疗婴儿颌面部巨大高流量血管瘤[J]. 介入放射学杂志, 2011, 20(11): 848-852.
[24] Gill JS, Bhardwaj A, Grover HS, et al.Oral haemangioma[J]. Case Rep Med, 2012, 2012: 347939.
[25] Margileth AM, Museles M.Cutaneous hemangiomas in children. Diagnosis and conservative management[J]. JAMA, 1965, 194(5): 523-526.
[26] Price CJ, Lattouf C, Baum B, et al.Propranolol vs corticosteroids for infantile hemangiomas: a multicenter retrospective analysis[J]. Arch Dermatol, 2011, 147(12): 1371-1376.
[27] Léauté-Labrèze C, Dumas de la Roque E, Hubiche T, et al. Propranolol for severe hemangiomas of infancy[J]. N Engl J Med, 2008, 358(24): 2649-2651.
[28] Siegfried EC, Keenan WJ, Al-Jureidini S.More on propranolol for hemangiomas of infancy[J]. N Engl J Med, 2008, 359(26): 2846-2847.
[29] Saint-Jean M, Léauté-Labrèze C, Mazereeuw-Hautier J, et al.Propranolol for treatment of ulcerated infantile hemangiomas[J]. J Am Acad Dermatol, 2011, 64(5): 827-832.
[30] Hermans DJ, van Beynum IM, Schultze Kool LJ, et al. Propranolol, a very promising treatment for ulceration in infantile hemangiomas: a study of 20 cases with matched historical controls[J]. J Am Acad Dermatol, 2011, 64(5): 833-838.
[31] Léauté-Labrèze C, Voisard JJ, Moore N.Oral Propranolol for Infantile Hemangioma[J]. N Engl J Med, 2015, 373(3): 284-285.
[32] 刘学键, 秦中平, 邰茂众, 等. 普萘洛尔治疗婴幼儿腮腺血管瘤的临床观察[J]. 中华口腔医学杂志, 2010, 45(5): 292-294.
[33] 李丽, 马琳. 普萘洛尔治疗婴儿重症血管瘤的疗效及不良反应[J]. 国际皮肤性病学杂志, 2010, 36(6): 325-327.
[34] Gottschling S, Schneider G, Meyer S, et al.Two infants with life-threatening diffuse neonatal hemangiomatosis treated with cyclophosphamide[J]. Pediatric Blood Cancer, 2006, 46(2): 239-242.
[35] Guo S, Ni N.Topical treatment for capillary hemangioma of the eyelid using beta-blocker solution[J]. Arch Ophthalmol, 2010, 128(2): 255-256.
[36] 郑家伟, 王绪凯, 江成鸿, 等. 外用马来酸噻吗洛尔治疗婴幼儿血管瘤中国专家共识[J]. 上海口腔医学, 2016, 25(6): 744-747.
[37] 李文明, 郭学利, 张盼, 等. 血管瘤的分类和治疗[J]. 肿瘤基础与临床, 2010, 23(6): 539-541.
[38] 黄锦华, 郭军. 口腔颌面部血管瘤激光治疗160例临床分析[J]. 临床医学, 2010, 30(4): 97-98.
[39] Fawcett SL, Grant I, Hall PN, et al.Vincristine as a treatment for a large haemangioma threatening vital functions[J]. Br J Plast Surg, 2004, 57(2): 168-171.
[40] Pandey A, Gangopadhyay AN, Upadhyay VD. Evaluation and management of infantile hemangioma: an overview [J]. Ostomy Wound Manage, 2008, 54(5): 16-18, 20, 22-26, 28-29.
[41] Herrero Hernández A, Escobosa Sánchez O, Acha García T.Successful treatment with vincristine in PHACES syndrome[J]. Clin Transl Oncol, 2007, 9(4): 262-263.
[42] Sugarman JL, Mauro TM, Frieden IJ.Treatment of an ulcerated hemangioma with recombinant platelet-derived growth factor[J]. Arch Dermatol, 2002, 138(3): 314-316.
[43] Garden JM, Bakus AD, Paller AS.Treatment of cutaneous hemangiomas by the flashlamp-pumped pulsed dye laser: prospective analysis[J]. J Pediatr, 1992, 120(4 Pt 1): 555-560.
[44] Morelli JG, Tan OT, Yohn JJ, et al.Treatment of ulcerated hemangiomas infancy[J]. Arch Pediatr Adolesc Med, 1994, 148(10): 1104-1105.
[45] David LR, Malek MM, Argenta LC.Efficacy of pulse dye laser therapy for the treatment of ulcerated haemangiomas: a review of 78 patients[J]. Br J Plast Surg, 2003, 56(4): 317-327.
[46] 凌冰, 陈东民, 周平, 等. 介入栓塞治疗颌面部血管瘤的临床应用[J]. 医学影像学杂志, 2012, 22(12): 2098-2099.